Ranir, LLC Announces the Acquisition of Placon... ( GRAND RAPIDS Mich. Jan. 12 /- Ran...)

Ranir, LLC Announces the Acquisition of Placontrol, Inc.

Date:1/12/2009

GRAND RAPIDS, Mich., Jan. 12 /PRNewswire/ -- Ranir, LLC, a leading consumer products oral care company, announced today that it has acquired Placontrol, Inc., a foremost manufacturer and marketer of interdental oral care products under the Plackers(R) trademark. Headquartered in San Diego, California, Placontrol is the founder of the convenience dental flosser. Terms of the transaction were not disclosed.

Ranir, headquartered in Grand Rapids, Michigan manufactures and markets consumer oral care products to leading retail customers and branded oral care companies in North America. Led by CEO Christine Henisee, Ranir has expanded its sales platform to include serving virtually all top chain drug stores, mass merchandisers, supermarkets, and discount retailers in North America along with some key global branded oral care companies. Ranir has an extensive line of consumer oral care products, including tooth-whitening wraps, whitening trays, dissolving whitening strips, manual and power toothbrushes, dental floss and flossers, travel kits, night protectors, and other oral care accessories.

"Teaming with Placontrol will accelerate our growth through enhanced new product development capabilities as well as increased supply chain efficiencies," said Henisee, who joined Ranir in 2003 and has more than 30 years of consumer products experience. "Placontrol is an innovation leader in the flosser category with a significant pipeline in oral care."

Placontrol's products are unique, patent-protected interdental and gum care products that have significant potential for growth. Plackers Dental Flossers and Interdental brushes are distributed in most major U.S. retail chains such as Walmart, CVS, Walgreens, Rite Aid, Dollar Tree and Kroger, in leading European retailers such as Tesco and Boots, and in 30 other countries worldwide. Ingram Chodorow, the founder of Placontrol, said, "Placontrol brings an
'/>"/>

SOURCE Ranir, LLC
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter of Fiscal Year 2009
2. Mindray Announces Preliminary 2008 Operating Results
3. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
4. Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue
5. Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
6. Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests
7. Oleen Pinnacle Announces Acquisition of Partners in Health Systems
8. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
9. Miami Beach Real Estate Attorney Announces Specialized Legal and Realty Services for Clients Buying Bank-Owned Luxury Miami Beach Condos
10. Genomma Lab Announces Initiation of Stock Repurchase Fund
11. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference

Post Your Comments:

(Date:3/9/2014)... reproductive potential to invade wild gene pools and should ... University of East Anglia (UEA). , Findings published today ... their wild counterparts, they are just as fertile. This ... into the wild posing threats to wild gene ... school of Biological Sciences said: "Around 95 per cent ...

(Date:3/7/2014)... University Medical Center (CUMC) researchers have found that decision-making ... a decision by a mere fraction of a second. ... characterized by abnormalities in cognitive function and lead to ... The study was published in the March 5 online ... , "Decision making isn,t always easy, and sometimes ...

(Date:3/7/2014)... PHOENIX, Ariz. March 7, 2014 In ... of Clinical Oncology (ASCO) has named Dr. Daniel ... Luminaries, celebrating 50 doctors who over the past ... Dr. Von Hoff, M.D., FACP, is Physician-In-Chief and ... (TGen), and Chief Scientific Officer for Scottsdale Healthcare,s ...

(Date:3/7/2014)... detecting and treating patients infected with emerging ... hospitals. A study from the Society for ... consortium of more than 200 hospitals collaborating ... could be contributing to the increase in ... the April issue of Infection Control ...

(Date:3/7/2014)... Researchers at Brigham and Women,s Hospital (BWH) in ... Maastricht University Medical Centre and Maastricht University School ... University of Edinburgh in the United Kingdom, have ... to 37 weeks gestation) increases the risk of ... the risk of developing these conditions increases as ...

Breaking Medicine News(10 mins):Health News:Farm salmon pose clear reproductive threat to wild gene pools 2 Health News:Ever-so-slight delay improves decision-making accuracy 2 Health News:Ever-so-slight delay improves decision-making accuracy 3 Health News:TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO 2 Health News:Emerging multi-drug resistant infections lack standard definition and treatment 2

[0] Farm salmon pose clear reproductive threat to wild gene pools [0] Ever-so-slight delay improves decision-making accuracy [0] TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO [0] Emerging multi-drug resistant infections lack standard definition and treatment [0] Pre-term birth and asthma

... , CROFTON, Md., July 22 Dr. Robert ... in Montgomery County in the Muddy Branch Square Shopping Center at ... open 365 days a year to serve children and adults when ... Center offers X-ray, laboratory and prescription services. , ...

... , REDWOOD CITY, Calif., July ... from its first Phase 2 clinical study evaluating the ... Sufentanil NanoTab(TM) PCA System for management of acute post-operative ... reliably self-administered sufentanil NanoTabs repeatedly over the 12-hour study ...

... , INDIANAPOLIS, July 22 , , , ... , Foreign Exchange Movements Lead to Improved Gross Margin Percent , ... forma non-GAAP) , Full-Year 2009 Reported ... to $4.24 per share , Pro forma non-GAAP EPS Guidance ...

... To ... functionality to its, Enterprise System that will streamline operational processes to maximize efficiency. ... processes that will improve productivity and reduce operating costs. , ... Plainview, NY (PRWEB) July 22, 2009 -- ...

... ... Collaborative (CAeHC), announced a successful demonstration of five community-based health information exchange (HIE) ... clinical health information to improve patient care. , ... San Francisco, CA (PRWEB) July 20, ...

... ... the most prolific and well-known cosmetic plastic surgeons in the world is ... as an expert on rhinoplasty, secondary rhinoplasty, and surgery to correct breathing ... P. Gunter is head of an elite team of experts, and ...

Nighttime Care Centers Announces New Urgent Care Medical Clinic in Montgomery County, Maryland AcelRx Announces Perfect Performance of Handheld Component of ARX-01 Sufentanil NanoTab PCA System in a Phase 2 Study Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance Fastrack Automates Workflow For Homecare Providers CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges Dr. Jack P. Gunter Assembles an Elite Cosmetic and Plastic Surgery Team in Dallas, Texas

(Date:1/15/2014)... Jan. 15, 2014 Novation, the leading health ... awarded several new IT value-added reseller (VAR) national ... organizations with IT goods and services at lower ... as well as value-added services such as initiative ... New Novation agreements were awarded to CDW ...

(Date:1/15/2014)... NEW YORK , January 15, 2014 ... subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly ... announced that on January 7, 2014, the Company,s board ... Ben-Zion Weiner as its new member of ... Weiner held executive positions with Teva Pharmaceutical Industries Ltd ...

(Date:1/15/2014)... , Jan. 15, 2014 Echo Therapeutics, Inc. ... device company developing its Symphony® CGM System as ... announced that Robert F. Doman , Executive ... present at "TEN", Noble Financial Capital Markets, Tenth ... will make a corporate presentation to prospective corporate ...

Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2 BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2 BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3 Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2 Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3

[0] New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals [0] BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors [0] Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference

... ... under review by the EMEA, SEATTLE, July 7 ... publication of results from its,randomized phase III trial comparing OPAXIO(TM) (paclitaxel ... status 2) patients with previously untreated non-small cell,lung cancer (NSCLC) in ...

... in August -, EXTON, Pa., July 2 ... of the pivotal efficacy portion of its,Phase III ... treatment of nasolabial folds, or wrinkles. The last,person ... follow-up visit,and collation of this data has begun. ...

Cached Medicine Technology:Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2 Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3 Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4 Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5 Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2 Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3

Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Borrelia burgdorferi Total Antibodies, IgG and/or IgM by ELISA with Reflex to IgG by Western Blot (Late Disease)Borrelia burgdorferi C6 Peptide Antibodies, Total by ELISA (CSF)Borrelia burgdorferi by PCR (Lyme Disease)Borrelia burgdorferi Antibody, IgM by Western Blot (CSF)